XML 180 R109.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Equity [Abstract]    
Summary of Common Stock

December 31,

    

June 30, 2022

    

2021

Shares of common stock issued

 

199,464

 

199,464

Shares of common stock reserved for issuance for:

 

  

 

Warrants

 

199

199

Stock options

 

17,161

15,703

Restricted stock units

 

8,063

3,041

Shares available for grant under 2014 Stock Incentive Plan

 

3,076

8,933

Shares available for sale under 2014 Employee Stock Purchase Plan

 

2,300

2,300

Total shares of common stock issued and reserved for issuance

 

230,263

229,640

In addition, the Company had reserved for issuance the following amounts of shares of its common stock for the purposes described below as of December 31, 2021 and 2020 (in thousands):

    

December 31,

2021

    

2020

Shares of common stock issued

 

199,464

 

140,450

Shares of common stock reserved for issuance for:

 

  

 

  

Warrants

 

199

 

2,247

Stock options

 

15,703

 

10,147

RSUs

 

3,041

 

Shares available for grant under 2014 Stock Incentive Plan

 

8,933

 

4,863

Shares available for sale under 2014 Employee Stock Purchase Plan

 

2,300

 

Total shares of common stock issued and reserved for issuance

 

229,640

 

157,707

Summary of Warrants Outstanding and Warrant Activity

    

Exercise 

    

    

December 31, 

    

    

    

    

June 30, 

Issued

Price

Expiration

2021

Issued

(Exercised)

(Cancelled)

2022

Mar-2018

$

0.55

*

Mar-2023

 

132

 

 

 

 

132

Nov-2017

$

0.55

*

Nov-2022

 

12

 

 

 

 

12

May-2015

$

11.83

Nov-2024

 

28

 

 

 

 

28

Nov-2014

$

11.04

Nov-2024

 

27

 

 

 

 

27

 

199

 

 

 

 

199

*

Exercise price shown (i) reflects modification and (ii) is subject to further adjustment based on down round provision added by amendment described in “Item 15. Exhibits and Financial Statement Schedules — Note 12. Stockholders’ Equity (Deficit)” in the audited annual consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

The following table sets forth the Company’s warrant activity for the year ended December 31, 2021 (in thousands):

    

Exercise 

    

    

December 31, 

    

    

    

    

December 31, 

Issued

Price

Expiration

2020

Issued

(Exercised)

(Cancelled)

2021

Jun-2019

$

1.47

 

Jun-2020

 

 

 

 

 

Mar-2018

$

0.55

*

Mar-2023

 

1,705

 

 

(1,573)

 

 

132

Nov-2017

$

0.55

*

Nov-2022

 

487

 

 

(475)

 

 

12

May-2015

$

11.83

 

Nov-2024

 

28

 

 

 

 

28

Nov-2014

$

11.04

 

Nov-2024

 

27

 

 

 

 

27

 

2,247

 

 

(2,048)

 

199

*

Exercise price shown (i) reflects modification described below and (ii) subject to further adjustment based on down round provision added by amendment described below.